Question · asked by 1 review
Hypertonic saline vs amiloride: Lung function: FEV1 mL (change from baseline)
- Population
- adults and children with cystic fibrosis
- Intervention
- Hypertonic saline
- Comparison
- amiloride
- Outcome
- Lung function: FEV1 mL (change from baseline)
The review found no eligible studies for this question.
What each review found
Current versions onlyNo studies found 4 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Hypertonic saline vs amiloride FEV1: change from baseline, short‐term · adults and children with cystic fibrosis The review found no eligible studies for this question. Nebulised hypertonic saline for cystic fibrosis (2023) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Hypertonic saline vs amiloride FEV1: change from baseline, long‐term · adults and children with cystic fibrosis The review found no eligible studies for this question. Nebulised hypertonic saline for cystic fibrosis (2023) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Hypertonic saline vs amiloride FEV1: change from baseline, short term · adults and children with cystic fibrosis The review found no eligible studies for this question. Nebulised hypertonic saline for cystic fibrosis (2018) · Cochrane Headline outcomes onlyearlier version CD001506.PUB4, superseded | no estimate extracted | Not reported | No studies found |
Hypertonic saline vs amiloride FEV1: change from baseline, long term · adults and children with cystic fibrosis The review found no eligible studies for this question. Nebulised hypertonic saline for cystic fibrosis (2018) · Cochrane Headline outcomes onlyearlier version CD001506.PUB4, superseded | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Nebulised hypertonic saline for cystic fibrosis 2023 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.